Stocks-SURF-Surface Oncology Inc

SURF Surface Oncology Inc

1.05 -0.02 (-1.87%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Surface Oncology Inc's revenues increased by 1,016.49% and amounted to 30.00M. Net income increased by 18.98% to -63.59M. Net assets decreased by NaN to 93.40M and EPS decreased from N/A to -1.14.
SURF's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
87.71%
Net Profit Margin
-690.73%
Operating Margin
N/A
Return On Investment
-27.29%